Nasdaq:US$13.77 (+0.25) | HKEX:HK$20.72 (+0.04) | AIM:£1.97 (+0.04)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate